CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Sight Sciences Fiscal Q1 2024 Earnings Report - CapyFin

Sight Sciences

SGHT · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 +16.00%Q2 2025 +19.54%Q1 2025 +1.32%Q4 2024 +2.89%Q3 2024 -17.06%Q2 2024 -18.89%Q1 2024 +6.62%Q4 2023 +6.78%Q3 2023 +19.77%Q2 2023 +11.04%Q1 2023 -0.40%Q4 2022 +4.86%Q3 2022 +60.91%Q2 2022 -3.86%Q1 2022 +11.20%Q4 2021 -10.06%Q3 2021 -2.45%Q2 2021 -4.69%Q4 2020 Q3 2020 Q2 2020 Q1 2020

May 02, 2024

•

Mar 31, 2024

Sight Sciences Q1 2024 Earnings Report

Previous year: $18.8M

Previous year: -$0.35

Total Gross Margin

Previous year: 84%

Total Operating Expenses

Adjusted Operating Expenses

Previous year: $15.8M

Cash and Equivalents

Previous year: $167M

Previous year: -$17.5M

Previous year: $197M

Sight Sciences

Unlock previous datapoints

Sight Sciences

Unlock previous datapoints

Revenue by Segment

Surgical Glaucoma Revenue

Unlock previous datapoints

CapyFin.com

Dry Eye Revenue

Unlock previous datapoints

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Sight Sciences

Sight Sciences Revenue by Segment